QVT Financial LP - Q1 2017 holdings

$3.22 Billion is the total value of QVT Financial LP's 77 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 39.2% .

 Value Shares↓ Weighting
XBI SellSPDR SERIES TRUSTput$404,231,000
-23.3%
5,829,700
-34.5%
12.55%
-21.6%
SellVERISIGN INCsdcv 3.250% 8/1$73,120,000
-5.8%
28,600,000
-17.3%
2.27%
-3.7%
MMYT SellMAKEMYTRIP LIMITED MAURITIUS$68,951,000
+44.3%
2,053,014
-7.6%
2.14%
+47.6%
NYT SellNEW YORK TIMES COcl a$26,594,000
+2.6%
1,846,822
-5.2%
0.83%
+5.0%
INTC SellINTEL CORP$21,184,000
-45.8%
587,314
-45.5%
0.66%
-44.6%
SellMICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$21,032,000
-75.4%
6,752,000
-78.7%
0.65%
-74.8%
NRE SellNORTHSTAR REALTY EUROPE CORP$18,764,000
-26.5%
1,664,363
-20.5%
0.58%
-24.8%
EQC SellEQUITY COMWLTH$17,317,000
-7.6%
554,688
-10.5%
0.54%
-5.4%
AVXS SellAVEXIS INC$16,754,000
+56.1%
220,356
-2.0%
0.52%
+59.5%
AMBA SellAMBARELLA INC$15,733,000
-10.0%
287,577
-11.0%
0.49%
-7.9%
ASMB SellASSEMBLY BIOSCIENCES INC$15,649,000
+91.4%
694,817
-12.2%
0.49%
+96.0%
COG SellCABOT OIL & GAS CORP$13,010,000
-32.5%
544,142
-34.0%
0.40%
-30.9%
XLRN SellACCELERON PHARMA INC$12,717,000
-0.4%
480,437
-4.0%
0.40%
+1.8%
SellDHT HOLDINGS INCdebt 4.500%10/0$11,190,000
-26.7%
11,440,000
-31.1%
0.35%
-24.8%
LBIO SellLION BIOTECHNOLOGIES INC$10,019,000
-3.2%
1,385,309
-7.6%
0.31%
-1.0%
XNCR SellXENCOR INC$7,208,000
-19.1%
301,325
-11.0%
0.22%
-17.3%
BLUE SellBLUEBIRD BIO INC$7,183,000
+22.4%
79,016
-16.9%
0.22%
+25.3%
TNK SellTEEKAY TANKERS LTDcl a$6,648,000
-16.2%
3,243,074
-7.6%
0.21%
-14.5%
NAT SellNORDIC AMERICAN TANKERS LIMIput$6,595,000
-55.3%
806,200
-54.1%
0.20%
-54.2%
ACAD SellACADIA PHARMACEUTICALS INC$6,431,000
-8.7%
187,055
-23.4%
0.20%
-6.5%
ICPT SellINTERCEPT PHARMACEUTICALS IN$6,263,000
-7.5%
55,380
-11.1%
0.20%
-5.3%
EPZM SellEPIZYME INC$6,096,000
-5.0%
355,445
-33.0%
0.19%
-3.1%
SellNOVELLUS SYS INCnote 2.625% 5/1$5,973,000
-93.8%
1,570,000
-94.9%
0.19%
-93.7%
TSRO SellTESARO INC$5,567,000
-12.2%
36,179
-23.2%
0.17%
-10.4%
BMRN SellBIOMARIN PHARMACEUTICAL INC$5,137,000
-1.9%
58,517
-7.4%
0.16%
+0.6%
RGNX SellREGENXBIO INC$3,733,000
-19.5%
193,432
-22.7%
0.12%
-17.7%
BLCM SellBELLICUM PHARMACEUTICALS INC$3,711,000
-19.4%
300,723
-11.0%
0.12%
-17.9%
KRE SellSPDR SERIES TRUSTs&p regl bkg$3,358,000
-48.2%
61,491
-47.3%
0.10%
-47.2%
AKTX SellAKARI THERAPEUTICS PLCsponsored adr$1,887,000
+29.8%
209,121
-19.0%
0.06%
+34.1%
TCON SellTRACON PHARMACEUTICALS INC$1,273,000
-25.6%
339,539
-11.0%
0.04%
-23.1%
PTN SellPALATIN TECHNOLOGIES INC$985,000
-56.2%
4,296,847
-32.5%
0.03%
-54.4%
SRLP ExitSPRAGUE RES LP$0-30,909
-100.0%
-0.02%
TSLA ExitTESLA MTRS INCput$0-44,660
-100.0%
-0.03%
OCRX ExitOCERA THERAPEUTICS INC$0-906,286
-100.0%
-0.06%
NAT ExitNORDIC AMERICAN TANKERS LIMI$0-284,237
-100.0%
-0.07%
HMLP ExitHOEGH LNG PARTNERS LP$0-175,000
-100.0%
-0.10%
FIT ExitFITBIT INCcl a$0-572,202
-100.0%
-0.13%
ATVI ExitACTIVISION BLIZZARD INC$0-133,900
-100.0%
-0.15%
ATHM ExitAUTOHOME INCsp adr rp cl a$0-201,900
-100.0%
-0.16%
ZXAIY ExitCHINA ZENIX AUTO INTL LTDads$0-6,074,805
-100.0%
-0.17%
YY ExitYY INC$0-190,700
-100.0%
-0.23%
IMAX ExitIMAX CORP$0-242,741
-100.0%
-0.23%
ExitTRINA SOLAR LIMITEDdbcv 3.500% 6/1$0-8,200,000
-100.0%
-0.24%
TSLA ExitTESLA MTRS INC$0-44,746
-100.0%
-0.29%
MRVL ExitMARVELL TECHNOLOGY GROUP LTDord$0-789,576
-100.0%
-0.33%
ExitWEBMD HEALTH CORPnote 2.500% 1/3$0-11,000,000
-100.0%
-0.35%
TSM ExitTAIWAN SEMICONDUCTOR MFG LTDput$0-400,000
-100.0%
-0.35%
BLK ExitBLACKROCK INCput$0-40,000
-100.0%
-0.46%
ExitCLOVIS ONCOLOGY INCnote 2.500% 9/1$0-24,795,000
-100.0%
-0.78%
IBB ExitISHARES TRcall$0-100,000
-100.0%
-0.81%
ExitXILINX INCnote 2.625% 6/1$0-29,215,000
-100.0%
-1.86%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings